HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
OFIX
Orthofix Medical Inc.
OFIX lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
OFIX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Weak |
OFIX's revenue and profitability are currently stable, but its cash flow and balance sheet are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
OFIX PE Valuation
OFIX has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
OFIX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect OFIX's losses to shrink, with revenue holding steady.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
OFIX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.11 | +$1.93 |
| Q2 2026 | -$1.53 | +$1.65 |
| Q1 2026 | -$1.50 | +$2.20 |
| Q4 2025 | -$2.33 | +$0.97 |
| Q3 2025 | -$3.04 | +$0.07 |
| Q2 2025 | -$3.18 | -$0.01 |
| Q1 2025 | -$3.70 | -$0.34 |
| Q4 2024 | -$3.30 | +$0.82 |
OFIX has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over OFIX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
OFIX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $207.9M | +1.1% |
| Q2 2026 | $210.9M | +3.8% |
| Q1 2026 | $196.7M | +1.6% |
| Q4 2025 | $219.9M | +2% |
| Q3 2025 | $205.6M | +4.6% |
| Q2 2025 | $203.1M | +2.3% |
| Q1 2025 | $193.6M | +2.7% |
| Q4 2024 | $215.7M | +7.6% |
OFIX's revenue has grown year over year for 15 quarters in a row: $208M last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.7% | +9 points |
| Q2 2026 | -3.9% | +4 points |
| Q1 2026 | -7.3% | +18 points |
| Q4 2025 | 0.2% | +5.5 points |
| Q3 2025 | -8.3% | +1.3 points |
| Q2 2025 | -7.9% | +4.7 points |
| Q1 2025 | -25% | -9.7 points |
| Q4 2024 | -5.3% | +3.8 points |
OFIX has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over OFIX on cash generation, producing positive trailing cash flow while its opponent burns cash.
OFIX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$14.1M | -666% |
| Q2 2026 | -$18.9M | -517% |
| Q1 2026 | -$28.3M | -$3.1M |
| Q4 2025 | $16.8M | +20% |
| Q3 2025 | $2.5M | -61% |
| Q2 2025 | $4.5M | +$4.9M |
| Q1 2025 | -$25.1M | +$4M |
| Q4 2024 | $14.1M | +$35.3M |
OFIX's free cash flow was −$44M over the past year, against −$4M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over OFIX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
OFIX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +272K shares |
| 1 year | +3.6% | +1.4M shares |
| 3 years | +108% | +21.4M shares |
OFIX has 41M diluted shares, up 3.6% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
OFIX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.2x | High |
| Q2 2026 | 8.6x | High |
| Q1 2026 | 10.8x | High |
| Q4 2022 | -3.2x | Net Cash |
| Q3 2022 | -3.0x | Net Cash |
| Q2 2022 | -2.6x | Net Cash |
| Q1 2022 | -3.4x | Net Cash |
| Q4 2021 | -4.1x | Net Cash |
OFIX's net debt is about 4.2 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
OFIX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.9 | Oversold |
| Stochastic | 8.4 | Oversold |
OFIX's weekly RSI is 30 (oversold) and its Stochastic is 8 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
OFIX PE vs Healthcare Sector
| Metric | OFIX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
OFIX has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
OFIX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.85 | 22% below |
| 20 week MA | $9.71 | 29% below |
| 50 week MA | $11.4 | 39% below |
| 100 week MA | $13.0 | 47% below |
| 200 week MA | $14.5 | 52% below |
OFIX is in a downtrend: it's below all five of its weekly moving averages, and 52% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over OFIX on returns for 2026, with the stronger performance.
OFIX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.0 | $42.6 | -7.5% |
| 2021 | $42.6 | $31.5 | -26% |
| 2022 | $31.5 | $19.3 | -39% |
| 2023 | $19.3 | $13.5 | -30% |
| 2024 | $13.5 | $17.5 | +30% |
| 2025 | $17.5 | $15.2 | -13% |
| 2026 YTD | $15.2 | $6.94 | -54% |
OFIX has finished lower in five of the last six years. It's down 54% so far in 2026.